- Filed
- Nov 29, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Nov 27, 2024 | 27.18M sh |
| Revenue | FY 2024 · Aug 31, 2024 | $135.56K |
| Stock Issued | FY 2024 · Nov 21, 2023 | 373.82K sh |
| Shares Diluted restated | FY 2024 · Aug 31, 2023 | 25.51M sh |
| Capex | FY 2024 · Aug 31, 2023 | $14.19K |
| Operating Cash Flow | FY 2024 · Aug 31, 2023 | −$1.67M |
| Cash And Equivalents | FY 2024 · Aug 31, 2023 | $779.05K |
| Current Liabilities | FY 2024 · Aug 31, 2023 | $964.64K |
| Total Liabilities | FY 2024 · Aug 31, 2023 | $1.17M |
| Current Assets | FY 2024 · Aug 31, 2023 | $2.07M |
| Total Assets | FY 2024 · Aug 31, 2023 | $79.02M |
| Eps Diluted restated | FY 2024 · Aug 31, 2023 | −$0.24 |
| Eps Basic restated | FY 2024 · Aug 31, 2023 | −$0.24 |
| Sga Expense | FY 2024 · Aug 31, 2023 | $6.06M |
| Net Income | FY 2024 · Aug 31, 2023 | −$6.06M |
| Operating Income | FY 2024 · Aug 31, 2023 | −$6.13M |
| Gross Profit | FY 2024 · Aug 31, 2023 | −$36.15K |
| Cost Of Revenue | FY 2024 · Aug 31, 2023 | $424.19K |